As debate continues over the cost and sustainability of GLP-1 [...]

Axplora has announced a €6.5 million investment at its Vizag [...]

Nucleus Network has acquired UK-based Hammersmith Medicines Research (HMR), a [...]

New data presented at the Alzheimer’s Association International Conference 2025 [...]

A new investigational HIV vaccine candidate, GRAdHIVNE1, has entered Phase [...]

New AI platform designed to support faster discovery, better study [...]

Appointments reflect strategic focus on infectious disease and medical affairs [...]

Investment led by aMoon will support US and EU commercialisation [...]

Contract manufacturer Symbiosis Pharmaceutical Services has announced the completion of [...]

OMNY Health has reached a major milestone, announcing that its [...]